Quoin Pharmaceuticals gets FDA rare pediatric disease designation for QRX003
Quoin Pharmaceuticals said the FDA granted Rare Pediatric Disease designation for QRX003 in Peeling Skin Syndrome. The item cites an original SEC filing and does not provide additional terms.